chr3-96840425-T-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001080448.3(EPHA6):c.385+25417T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0316 in 152,236 control chromosomes in the GnomAD database, including 111 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.032 ( 111 hom., cov: 32)
Consequence
EPHA6
NM_001080448.3 intron
NM_001080448.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.0750
Publications
2 publications found
Genes affected
EPHA6 (HGNC:19296): (EPH receptor A6) Predicted to enable transmembrane-ephrin receptor activity. Predicted to be involved in axon guidance; positive regulation of kinase activity; and transmembrane receptor protein tyrosine kinase signaling pathway. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0637 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| EPHA6 | NM_001080448.3 | c.385+25417T>G | intron_variant | Intron 1 of 17 | ENST00000389672.10 | NP_001073917.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| EPHA6 | ENST00000389672.10 | c.385+25417T>G | intron_variant | Intron 1 of 17 | 1 | NM_001080448.3 | ENSP00000374323.5 | |||
| EPHA6 | ENST00000506569.1 | c.217+25417T>G | intron_variant | Intron 1 of 3 | 1 | ENSP00000425132.1 | ||||
| EPHA6 | ENST00000470610.6 | c.385+25417T>G | intron_variant | Intron 1 of 4 | 2 | ENSP00000420598.2 |
Frequencies
GnomAD3 genomes AF: 0.0317 AC: 4815AN: 152118Hom.: 112 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
4815
AN:
152118
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0316 AC: 4814AN: 152236Hom.: 111 Cov.: 32 AF XY: 0.0304 AC XY: 2259AN XY: 74414 show subpopulations
GnomAD4 genome
AF:
AC:
4814
AN:
152236
Hom.:
Cov.:
32
AF XY:
AC XY:
2259
AN XY:
74414
show subpopulations
African (AFR)
AF:
AC:
803
AN:
41568
American (AMR)
AF:
AC:
453
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
AC:
134
AN:
3468
East Asian (EAS)
AF:
AC:
360
AN:
5170
South Asian (SAS)
AF:
AC:
305
AN:
4818
European-Finnish (FIN)
AF:
AC:
92
AN:
10626
Middle Eastern (MID)
AF:
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2562
AN:
67994
Other (OTH)
AF:
AC:
79
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
244
488
731
975
1219
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
303
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.